Related by context. All words. (Click for frequent words.) 69 Pharmacogenomics 66 Toxicogenomics 66 Population Genomics 66 Metabolic Disease 65 J Nutr 64 See CLINICAL PHARMACOLOGY 64 Mutagenesis 64 Autoimmune Disease 63 Chemoprevention 63 Reproductive Biology 63 Neurodegenerative Disorders 63 Molecular Basis 63 Anticancer Agents 63 Pharmacogenomic 63 Cytochrome P# 62 Gastric Cancer 62 Neurotherapeutics 62 Motility 62 Cell Signaling 62 Therapeutic Targets 62 Prostate Disease 61 Signal Transduction 61 Metabolomics 61 Genetic Variation 61 Molecular Genetic 61 Cytogenetics 61 pharmacogenetics 61 Oxidative Stress 61 Kinase Inhibitors 61 Exp Clin 61 Oligonucleotides 61 Immunotherapeutic 61 Genetic Disorders 61 VKORC1 61 Genetic Testing 61 Novel Therapeutic 61 Neurochemistry 61 Molecular Oncology 61 Neuroprotection 61 ANN INTERN MED 60 Biomarker Discovery 60 Maven Semantic 60 Developmental Therapeutics 60 Cannabinoid 60 Translational Medicine 60 Digestive Diseases 60 Diagnostic Tests 60 Cardiovascular Outcomes 60 Prenatal Diagnosis 60 J Clin 60 Novel Therapies 60 Immune Therapy 60 #:#-# [024] 60 Arch Neurol 60 Phenotype 60 Molecular Mechanisms 60 Retrovirus 60 Proteomics 60 Severe Asthma 60 Protein Biomarker 60 #:#-# [037] 60 Investigational Drug 60 Pharmacogenetic 60 #:#-# [023] 60 Hematologic Malignancies 60 Personalised Medicine 60 Anticancer Drug 60 Dyslipidemia 60 Slow Progression 60 Protein Interactions 60 Atherosclerosis Research 60 Genitourinary 60 Phase IIb Clinical Trial 60 Islet Transplantation 60 Pediatric Endocrinology 59 Psychobiology 59 Cognitive Deficits 59 #-# Full Text 59 Transdermal Delivery 59 Immunobiology 59 Inflammatory Diseases 59 Bipolar Disorders 59 Computational Genomics 59 Schizophrenia Treatment 59 Glycobiology 59 RNAi Therapeutics 59 Epidemiological Studies Unit 59 Clinical Outcome 59 Inflammatory Markers 59 FDA CDER 59 Combination Treatment 59 Neurodegenerative Disease 59 Cancer Immunotherapy 59 Small Molecule 59 Novel Therapeutics 59 Genetic Medicine 59 Cancer Vaccines 59 Estrogen Receptor 59 #:#-# [001] 59 Nanobiotechnology 59 Autoimmune Diseases 59 Nanotoxicology 59 Prostate Cancer Treatment 59 Shows Promise Against 59 Nuclear Receptors 59 Fabry Disease 59 Geriatric Medicine 59 Pharmacoepidemiology 59 PGx 59 Tumor Microenvironment 59 RNA Therapeutics 59 Nutritional Metabolism 59 Myelodysplastic Syndromes 59 Molecular Epidemiology 59 Neuroanatomy 59 Treating Chronic 59 Oncologic 59 Hepatocellular Carcinoma 59 Insulin Resistance 59 Lipid Metabolism 59 Protein Structure 59 Biologic Therapy 59 Pulmonary Arterial Hypertension 59 Nicotine Addiction 59 Biomarker Study 59 Intravenous Formulation 59 Molecular Diagnostic 59 Crit Rev 59 Thrombophilia 58 Lung Cancer Drug 58 Hematological 58 Pathogenesis 58 Tumor Angiogenesis 58 #:#-# [006] 58 Novel Inhibitor 58 Patient Oriented 58 Systemic Delivery 58 Genetic Diseases 58 Differential Diagnosis 58 Adenoma 58 Malaria Parasite 58 Intervention Trial GAIT 58 J Clin Endocrinol Metab 58 J Neurosurg 58 Preclinical Study 58 Cardiotoxicity 58 Liprotamase 58 Cancer Biomarkers 58 Predisposition 58 Cardiometabolic 58 Minimally Invasive Treatment 58 Diagnostic Criteria 58 Neuroimmunology 58 Bioequivalence 58 Analytical Tool 58 FRCPath 58 Dementias 58 Glucosamine Chondroitin Arthritis 58 FRACP 58 Vaccine Trials 58 Therapeutic Strategies 58 Neurodegenerative 58 Cytometry 58 Early Diagnosis 58 Pathophysiology 58 Immunochemistry 58 Metabolic Bone Diseases 58 Renal Cancer 58 Hemostasis 58 Mitochondrial Medicine 58 Tuberculosis Vaccine 58 Dendritic Cells 58 Immunologic 58 Neurovirology 58 Gene Linked 58 Trandolapril 58 J Am Acad 58 Bladder Cancer 58 Diabetes Obesity 58 Protein Expression 58 Clinical Biochemistry 58 Therapeutic Potential 58 Protein Interaction 58 Novel Treatments 58 Molecular Virology 58 Clinical Evaluation 58 Prolongs Survival 58 RNA Interference 58 Skeletal Muscle 58 Pancreas Cancer 58 Immunopharmacology 58 Intensive Care Medicine 58 Neuropharmacology 58 Obstet Gynecol 58 Preclinical Models 58 Initiates Clinical Trial 58 Epithelial Cell 58 Mouse Models 58 Retroviral 58 Investigational Treatment 58 Gene Expression 58 IGSP 58 Drug Metabolism 58 Epigenetics 58 Anticancer Agent 58 #:#-# [035] 58 Int J 58 Am J Geriatr 58 Neuroepidemiology 58 Breast Cancer Metastasis 58 Iron Overload 57 Rheumatoid Arthritis Patients 57 Environ Health Perspect 57 Innate Immunity 57 Cancer Therapies 57 Mutation Analysis 57 Mood Disorders 57 Heart Failure Patients 57 J Consult Clin 57 #:#-#,# CrossRef Medline [002] 57 Biomarker 57 Atopic Dermatitis 57 Eukaryotic 57 Acute Treatment 57 Severe Sepsis 57 Galectin 3 57 Eur J 57 Antiviral Therapy 57 Pulmonary Hypertension 57 Gynecol Oncol 57 Oral Fingolimod 57 Cell Differentiation 57 Immunosuppressant 57 Clinical Pharmacy 57 Novel Approaches 57 CALGB 57 Metabolic Disorders 57 Curr Opin 57 Microbial Pathogenesis 57 Clinical Trials 57 Tyrosine Kinase Inhibitor 57 Prospective Randomized 57 Brain Tumor Therapy 57 Metabolic Diseases 57 TB Vaccine 57 Developmental Genetics 57 Asthma COPD 57 Pediatric Allergy 57 #:#-# [033] 57 Immune Tolerance Network 57 Drug Approvals 57 Clinical Trials Unit 57 Mimetics 57 Diabetes Endocrinology 57 NIMH Mood 57 Anticoagulation 57 Functional Neurosurgery 57 Treating Depression 57 HCV Protease Inhibitor 57 Molecular Pathogenesis 57 Phenylketonuria 57 Fondaparinux 57 Intervention Effectiveness CATIE 57 Cell Signalling 57 DNA Methylation 57 J Cardiovasc 57 Adult Stem Cell Therapy 57 Viral Infections 57 Hypercholesterolemia 57 Diabetes Res Clin 57 Therapeutic Advances 57 Biochemical Pharmacology 57 #:#-# [031] 57 Nat Rev 57 Gene Silencing 57 Human Leukocyte Antigen 57 Subtypes 57 Population Genetics 57 Investigational Compound 57 Signaling Pathways 57 Predictive Toxicology 57 Drug Shows Promise 57 Neoadjuvant Chemotherapy 57 Myoblast 57 Mouse Model 57 Clin J 57 Lung Cancer Treatment 57 Allergic Diseases 57 Intervention Effectiveness 57 Individualized Therapy 57 Genomic 57 Clinical Decision Making 57 Bucindolol 57 Atomoxetine 57 Gastrointestinal Disorders 57 #:#-#,# [003] 57 Scripps Genomic Medicine 57 Inflammatory Bowel Disease 57 Urologic Cancer 57 Phytotherapy 57 Bone Marrow Transplants 57 Respiratory Virus 57 Pregnancy Outcomes 57 Systematic Review 57 Clinical Trial Enrollment 57 Anticoagulant 57 vitro pharmacology 57 Pharmacoeconomic 57 Pathology Microbiology 57 Cancer Biomarker 57 Cardiovascular Diseases 57 Arterial Disease 57 J Am Coll 57 Clinical Pharmacology 57 Immune Mediated 57 Breast Cancer Recurrence 57 Free Full Text 57 Monoclonal Antibodies 57 Pelvic Pain 57 Interstitial Cystitis 57 Antithrombotic 57 Pharmacokinetic Study 57 Comparative Effectiveness 57 Cancer Genetics 57 Protein Folding 57 Observational Study 57 Arthritis Musculoskeletal 57 J Pediatr 57 Polymorphisms 57 Fibromyalgia Syndrome 57 Diagnosis Treatment 57 Postdoctoral Position 57 Clinical Guideline 57 Pancreatic 57 Male Contraceptive 57 Clinical Genetics 57 Chronic Heart Failure 57 Subgroup Analysis 57 PYY #-# 57 Nutrigenomics 57 Artificial Pancreas 57 Anti Tumor 57 Antibody Discovery 57 MassGeneral Institute 56 #:# -# [004] 56 Immunological 56 Mol Cell 56 Hospital Acquired Pneumonia 56 Cancer Stem Cells 56 Brain Disorders 56 Acute Pain 56 Patients Treated With 56 Pulmonary Diseases 56 Adjuvant Chemotherapy 56 Drug Discovery 56 Treatment Algorithms 56 Acute Liver Failure 56 Mg Uk 56 #:#-# [007] 56 Nat Genet 56 Prognostic Value 56 Blood Stem Cells 56 Cellular Therapy 56 Genetic Epidemiology 56 Genetic Marker 56 Psychiatry #:#-# [002] 56 Patient Registry 56 Hepatitis C Virus 56 Metabolic Disorder 56 Am J Clin 56 Neuropathic Pain 56 Growth Hormone Deficiency 56 Aneuploidy 56 Treat Parkinson Disease 56 Stem Cell Treatment 56 Immunotherapeutics 56 Aurora Kinase 56 Treating Prostate Cancer 56 Recombinant Protein 56 Rotavirus Vaccine 56 Bioavailability 56 Musculoskeletal Diseases 56 Epithelial 56 Personalized Medicine 56 Medical Oncologist 56 Combination Therapy 56 Neurodegenerative Diseases 56 Stomach Cancer 56 ERYtech 56 Genetic Variations 56 Integrative Neuroscience 56 Interferon Beta 56 Benign Prostatic Hyperplasia 56 Insulin Sensitivity 56 Initiates Phase III 56 Genomic Medicine 56 Polymorphism 56 Clinical Research 56 Nonalcoholic Fatty Liver Disease 56 Antifungals 56 Synthetic Peptide 56 Int J Radiat Oncol 56 Cancer Immunotherapeutics 56 Diabetic Neuropathy 56 Cancer Treatments 56 Whole Genome 56 Menstrual Cycle 56 MD FRCP 56 cardio renal 56 Preterm Birth 56 Oncogene 56 Antisense Drug 56 Combo Therapy 56 Pharmacology 56 Prolongs Life 56 Inherited Disease Research 56 Schizophrenia Drug 56 Cancer Res 56 Genomics 56 Protein Kinase 56 FASEB J. 56 Novel Antibiotic 56 Vaccine Adjuvant 56 Breast Oncology 56 Hematopoietic Stem Cell Transplantation 56 Newly Diagnosed 56 #:# -# [002] 56 Molecular Biomarkers 56 Liver Failure 56 Consultant Physician 56 Hormone Replacement 56 Nicotine Vaccine 56 Clinical Effectiveness 56 Arch Intern Med 56 Cardiac Rhythm 56 Breast Cancer Treatment 56 Successfully Completes Phase 56 Meets Primary Endpoint 56 Gynecologic 56 Antiplatelet 56 Innate Immune 56 Molecular Genetics 56 Therapeutic Agents 56 Cognitive Impairment 56 Genetic Susceptibility 56 Lung Injury 56 Agios Pharmaceuticals 56 Dose Escalation 56 Surgical Outcomes 56 Observational Studies 56 Marrow Transplant 56 Clinical Trials Consortium 56 Sustained Release 56 Fertility Treatment 56 Postmenopausal Women 56 Malignancies 56 Statistical Genetics 56 Phase III Clinical Trial 56 Menopausal Symptoms 56 Phase 2b Clinical Trial 56 Therapeutic Efficacy 56 Cancer Biology 56 Bone Marrow Transplantation 56 Allergic Rhinitis 56 Thiazolidinediones 56 Extracellular Matrix 56 Researchers Identify 56 Clinical Practice Guidelines 56 M.D. Ph.D. 56 Smooth Muscle 56 Kidney Transplant Patients 56 Neurobiological 56 Commercialize Novel 56 Intervention Trial 56 Advanced Prostate Cancer 56 Rhinosinusitis 56 Expression Profiling 56 Neurodevelopment 56 J Clin Oncol 56 Neoadjuvant 56 Protein Function 56 Clinical Proteomics 56 Osteoarthritis Patients 56 Therapeutic Effects 56 Antipsychotic Drug 56 Hormone Therapy 56 Glucocorticoid 56 Am J Epidemiol 56 #:#-# [025] 56 Molecular Diagnostic Test 56 Diabet Med 56 Pharmacotherapy 56 Nucleic Acids 56 Drug Interactions 56 #:# -# [006] 56 Lung Cancer Trial 56 Rheumatoid Arthritis Drug 56 Therapeutic Antibody 56 Thromb Haemost 56 Targeted Therapy 56 Matthew Meyerson 56 Genetic Predisposition 56 Whole Genome Sequencing 56 Antihypertensive 56 CrossRef Medline 56 Breast Cancer Cells 56 EMBO J. 56 Genetic Variant 56 Genes Identified 56 Proteomic 56 Patient Outcomes 56 Monoclonal antibody 56 Acute Heart Failure 56 TNF Alpha 56 HER2 Positive 56 Paediatric Allergy 56 Targeted Therapies 56 Stem Cell Transplant 56 Surgical Treatment 56 Cardiovascular Genetics 56 Male Infertility 55 Bioanalysis 55 Ziprasidone 55 Immune Cell 55 Protein Therapeutics 55 Clinical Neurology 55 UM Comprehensive Cancer 55 Dendritic cell 55 Endocrinol 55 Developmental Therapeutics Program 55 Reduces Mortality 55 Therapy Shows Promise 55 Cellular Biochemistry 55 Pluripotent Stem Cells 55 Hereditary Cancer 55 Neurotoxicity 55 Protein Synthesis 55 Chronic Myeloid Leukemia 55 Acute Stroke 55 Allergy Cardiovascular 55 Molecular Cancer 55 Etiology 55 Pharmaceutical Chemistry 55 Erectile Dysfunction Drug 55 Biopharmaceutical Industry 55 Multiple Myeloma Patients 55 Juvenile Idiopathic Arthritis 55 Molecular Medicine 55 Drug Candidate 55 MMR Vaccine 55 Medicinal Chemistry 55 Reproductive Toxicology 55 Gastrointestinal Oncology 55 Hepatitis C Treatment 55 Gene Variants 55 Invasive Breast Cancer 55 Aggressive Prostate Cancer 55 Degarelix 55 Pediatric Sleep 55 Tesmilifene 55 Sapacitabine 55 epigenetic therapies 55 ProfNet Wire Health 55 Refractory Angina 55 Improve Diagnosis 55 Bladder Control 55 Randomized Study 55 Martinos Center 55 J Child Adolesc 55 Aptamer 55 Neurological Diseases 55 Drug Prevents 55 Pediatric Adolescent 55 Pediatric Diabetes 55 Breast Tumor 55 Lowers Risk 55 Neonatal Medicine 55 Transcriptome 55 Psychol 55 Mycophenolate Mofetil 55 Clinical Antipsychotic Trials 55 Tumor Suppressor 55 Advanced Melanoma 55 Pharmacoeconomics 55 Neuroendocrine Tumor 55 Cancer Genome 55 Cellular Immunology 55 Cardiovascular Magnetic Resonance 55 Bert Vogelstein 55 Novel Oral 55 Pediatric Neurology 55 J Med 55 Neuroendocrine 55 Antigens 55 Neural Stem Cells 55 Pediatric Rheumatology 55 Gene Variant 55 Adjuvant Treatment 55 Bone Metastases 55 Relapsing Multiple Sclerosis 55 Microarray 55 Malaria Vaccine 55 Chronic Kidney 55 Genes Linked 55 Cell Proliferation 55 Glatiramer Acetate 55 Osteoporosis Drug 55 Sleep Disturbances 55 Leukemias 55 Prostate Cancer Patients 55 Inflammatory Disease 55 Oncol 55 Neurodevelopmental 55 Coronary Revascularization 55 Lymphoid 55 Acute Decompensated Heart Failure 55 Gene Mutation 55 Synthetic Chemistry 55 #:#-# [029] 55 Disease Modifying 55 Inactivation 55 aripiprazole Abilify 55 Effective Treatments 55 Mesenchymal Stem Cells 55 Epilepsy Surgery 55 Clinical 55 Transplant Rejection 55 Biobehavioral 55 Aggressive Reduction 55 Metabolites 55 Autoimmunity 55 Recombinant Human 55 Venous Thromboembolism 55 Drug Pipeline 55 Genetic Makeup 55 Hyperlipidemia 55 Renal Anemia 55 Cognitive Function 55 Protease Inhibitors 55 Breast Cancer Survival 55 Novel Vaccine 55 JAK Inhibitor 55 Experimental Therapeutics 55 Lipodystrophy 55 Ann Rheum Dis 55 Genes Involved 55 Hematopoietic Stem Cell 55 Companion Diagnostics 55 Novel Mechanism 55 Levels Linked 55 Eur Urol 55 Mol Med 55 Randomized Controlled Trials 55 Pharmacodynamics 55 Autoimmune Disorders 55 Beta Blocker 55 Allogeneic 55 Complementary Therapies 55 Dehydrogenase 55 Urogynecology 55 Neck Cancer 55 Psychiatric Services #:#-#,# 55 Genotyping Test 55 Clinical Practice Guideline 55 Cell Transplant 55 Treated Patients 55 BIIR 55 #:#-#,# Medline 55 Fungal Infections 55 J Allergy Clin 55 Cardiac Electrophysiology 55 Osteopontin 55 Gamunex C 55 Study Casts Doubt 55 #:#-# [040] 55 Combination REOLYSIN R 55 Nonclinical 55 Immune Tolerance 55 Hepatocellular 55 ACE Inhibitor 55 Surgical Pathology 55 Lung Cancer Survival 55 Antiangiogenic 55 Renal Cell Carcinoma 55 Functional Genomics 55 Geriatric Cognitive Disorders 55 Epitopes 55 Elvitegravir 55 Peripheral Arterial 55 NCI Cancer 55 Progressive Multifocal Leukoencephalopathy 55 Biol Phys 55 Pediatric Asthma 55 Hematopoietic Stem Cells 55 Immunol 55 #:# -# [003] 55 Azacitidine 55 Meta Analysis 55 #:#-#,# [002] 55 Investigator Initiated 55 Naive Patients 55 Prostate Cancer Risk 55 Technosphere ® 55 Chronic Pelvic Pain 55 Clinical Psychopharmacology 55 Anticancer Activity 55 Vaccine Protects Against 55 Pemphigus 55 Circulating Tumor Cells 55 Genome Sequencing 55 Androgen 55 Br J 55 Excretion 55 Solid Tumors 55 #:#-# [018] 55 Laryngeal Cancer 55 Geodon ziprasidone 55 Neoplasms 55 Sexual Dysfunction 55 Hans Clevers 55 UCSF Diabetes 55 Chronic Sinusitis 55 Reduced Risk 55 Conatus Pharmaceuticals 55 Transplantation Surgery 55 Antibiotic Resistant 55 Behavioral Neurobiology 55 Cancer Genetic Markers 55 Nanoemulsion 55 Anticonvulsant 55 Genotyping 55 Macromolecular 55 Membrane Proteins 55 Annu Rev 55 Adjuvant Breast Cancer 55 Prostate Cancer Vaccine 55 Transthyretin 55 ScD MPH 55 Mucosal Immunology 55 Anesth 55 Mitochondrial Dysfunction 55 Nicotinic 55 Nahum Sonenberg 55 Infected Patients 55 Neural Stem Cell 55 Erkki Ruoslahti 55 Preclinical Evaluation 55 Clinical Significance 55 NIAID Laboratory 55 Chemotherapeutic Agents 55 Genomic Analysis 54 Complicated Skin 54 Toxicological Sciences 54 Cutaneous T 54 Therapeutic Antibodies 54 High Throughput Biology 54 Regado Biosciences 54 Phenotypes 54 Treatment Shows Promise 54 Circadian Clock 54 Topical Treatment 54 Hematologic 54 Renal Transplantation 54 NCIC Clinical Trials 54 Ischemic Stroke 54 Overactive Bladder 54 Reperfusion Injury 54 Emerging Infectious Disease 54 Neuromuscular Disease 54 Stakeholder Opinions 54 Psychopharmacology 54 Treatment Naive Patients 54 DNA Sequencing 54 Biological Therapy 54 Adiposity 54 RNAi Therapeutic 54 Romidepsin 54 genes CYP#C# 54 Clinical Trial Results 54 Inhaled Liposomal Ciprofloxacin 54 pharmacogenetic testing 54 Multicenter Study 54 Experimental Therapeutics Program 54 Tumor Suppressor Gene 54 Autologous Stem Cell Transplantation 54 Smallpox Vaccine 54 Human Genome Variation 54 Cardiac Stem Cell 54 Chronic Rhinosinusitis 54 Erythropoietic 54 Recurrent Breast Cancer 54 Autoimmune 54 Brain Function 54 kidney urologic 54 Vector Borne 54 Suppl. 54 Teratology 54 Protein Involved 54 Pharmacother 54 Ovarian Cancer Patients 54 Advanced Heart Failure 54 Therapeutic Vaccines 54 Epidermal Growth Factor Receptor 54 Vascular Medicine 54 Lupus Drug 54 Left Ventricular Dysfunction 54 Edward Giovannucci 54 Related Diseases 54 Idiopathic Pulmonary Fibrosis 54 Brain Stimulation 54 Biol 54 Pathobiology 54 Protein Protein Interactions 54 Ann Oncol 54 Urinary Incontinence 54 Scientists Identify 54 Antimicrobial Chemotherapy 54 abstr 54 Psychotic Disorders 54 Enlarged Prostate 54 Antigen Specific 54 Leukemia Cells 54 Sipuleucel T 54 TRO# 54 Study ADCS 54 Pharmacologic 54 Prostate Cancer Survival 54 Female Urology 54 Myelodysplastic Syndrome MDS 54 Children Brain Tumour 54 Pediatric Pulmonology 54 Risk Stratification 54 Demonstrated Significant 54 #:#-# [032] 54 Bipolar Mania 54 Interferon Alfa 54 Genotype 54 Secondary Hyperparathyroidism 54 Male Fertility 54 #p# [003] 54 Signaling Pathway 54 Patients Receiving 54 Glycomics 54 PMID # [002] 54 Anti Infective 54 Survivorship Program 54 Thyroid Cancer 54 CLINICAL PHARMACOLOGY 54 Addict Behav 54 Postdoc 54 Vaccine Adjuvants 54 Diabetic Foot Ulcer 54 Joslin Diabetes 54 Endoplasmic Reticulum 54 Chronic Inflammation 54 MD MSHS 54 Nuclear Receptor 54 Generalized Anxiety Disorder 54 metabonomics 54 Anticancer Drugs 54 #:#-# [020] 54 NanoBioTechnology 54 Stem Cell Therapies 54 Physiology Seminar 54 Trace Element 54 Cardiovascular Disease Risk 54 Diabetology 54 Glycosylation 54 Behavioral Pharmacology 54 IND Application 54 Ann Emerg Med 54 Improves Outcomes 54 Supportive Care 54 Seasonal Influenza Vaccine 54 Thrombotic 54 FASN 54 Angiogenic 54 Disease Diagnosis 54 Dose Ranging Study 54 Glucose Metabolism 54 Hereditary Breast 54 Diabetic Patients 54 Protease 54 Demonstrates Efficacy 54 abacavir Ziagen 54 Molecular Mechanism 54 Consortium ICGC 54 Genetic Markers 54 Molecular Evolution 54 Gastrointestinal Disease 54 Investigational Agent 54 Antibiotic Resistance 54 Granted Orphan Drug 54 Molecular Pharmacology 54 Peripheral Blood 54 Low Incidence 54 Psychiatry #:#-# [003] 54 Clinical Physiology 54 Preclinical Development 54 Developmental Origins 54 Survival Benefit 54 Lupus Nephritis 54 Oral Presentation 54 Lipid Lowering 54 Psychiatric Disorders 54 Cutaneous Melanoma 54 Pediatric Psychopharmacology 54 Toxicol 54 Phase Ib Clinical Trial 54 Childhood Asthma 54 Vaccine Immunology 54 WHO Collaborating Centre 54 Therapeutic Approaches 54 Protein Linked 54 Parathyroid 54 Motility Disorders 54 Pituitary 54 Genome Wide 54 Molecular Genetics Laboratory 54 Pediatric Gastroenterology 54 pioglitazone hydrochloride 54 Hemodialysis Patients 54 Treatment Reduces 54 RhuDex 54 epigenomics 54 Uterine Fibroid 54 Antipsychotic 54 Clinical Trial Data 54 Helicobacter Pylori 54 Predict Prostate Cancer 54 Multidrug Resistant 54 Thromboembolic 54 Prevalence Estimates 54 Addiction Psychiatry 54 Alzheimer Disease Genetics 54 CNS Disorders 54 FDA Okays 54 Vaccine Shows Promise 54 Psoriasis Drug 54 Transcription Factor 54 Asthma Treatment 54 Antifungal 54 Irritable Bowel 54 neuropsychiatric diseases 54 Gluten Intolerance 54 Epstein Barr Virus EBV 54 #:#-# [027] 54 Double Blind Randomized 54 Kenneth Kinzler 54 Lipid Clinic 54 Tyrosine Kinase Inhibitors 54 Nutrition Metabolism 54 #:#-# [003] 54 Carcinoid 54 Migraine Treatment 54 Cell Adhesion 54 PhD DSc 54 Phase 2b Study 54 Improved Survival 54 genetic epidemiology 54 Pooled Analysis 54 Brain Plasticity 54 OBBeC 54 Kinase Inhibitor 54 Phase 2a Clinical Trial 54 Molecular Carcinogenesis 54 Theranostics 54 Biostatistician 54 Endothelial Dysfunction 54 Inflammatory Arthritis 54 cliniques de Montreal 54 Systemic Lupus Erythematosus SLE 54 Dermatopathology 54 Developmental Psychopathology 54 aurora kinase 54 reverse vaccinology 54 Drug Combo 54 ST Segment Elevation 54 Adult ADHD 54 Proteasome 54 SGLT2 inhibitors 54 Phase 2b Trial 54 Hormone Receptor Positive 54 Sequencing Systems 54 number NCT# ClinicalTrials.gov 54 Epigenome 54 Prognostic Factors 54 Human Embryonic Stem 54 Initiate Phase 54 Wellstat 54 Genetic Mutation 54 Parathyroid Hormone 54 Biomolecular Sciences 54 Immunohistochemistry 54 Beneficial Effects 54 Immunosuppressive 54 Inflammatory Bowel Diseases 54 Neuro oncology 54 Kidney Transplantation